Back to Search
Start Over
Use of Renin-Angiotensin System Blockers During the COVID-19 Pandemic: Early Guidance and Evolving Evidence.
- Source :
-
The Canadian journal of cardiology [Can J Cardiol] 2020 Aug; Vol. 36 (8), pp. 1180-1182. Date of Electronic Publication: 2020 Jun 02. - Publication Year :
- 2020
- Subjects :
- Angiotensin-Converting Enzyme 2
COVID-19
Humans
Patient Care Management
Peptidyl-Dipeptidase A metabolism
Practice Guidelines as Topic
SARS-CoV-2
Virus Internalization drug effects
Angiotensin II Type 1 Receptor Blockers pharmacology
Angiotensin-Converting Enzyme Inhibitors pharmacology
Betacoronavirus physiology
Coronavirus Infections epidemiology
Coronavirus Infections therapy
Coronavirus Infections virology
Heart Failure drug therapy
Hypertension drug therapy
Pandemics
Pneumonia, Viral epidemiology
Pneumonia, Viral therapy
Pneumonia, Viral virology
Renin-Angiotensin System drug effects
Renin-Angiotensin System physiology
Subjects
Details
- Language :
- English
- ISSN :
- 1916-7075
- Volume :
- 36
- Issue :
- 8
- Database :
- MEDLINE
- Journal :
- The Canadian journal of cardiology
- Publication Type :
- Editorial & Opinion
- Accession number :
- 32502522
- Full Text :
- https://doi.org/10.1016/j.cjca.2020.05.033